• Baggen, J., Thibaut, H.J., Strating, J.R.P.M., van Kuppeveld, F.J.M., 2018. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 16, 368–381.

  • Fang, Y., Liu, Z., Qiu, Y., Kong, J., Fu, Y., Liu, Y., Wang, C., Quan, J., Wang, Q., Xu, W., Yin, L., Cui, J., Xu, Y., Curry, S., Jiang, S., Lu, L., Zhou, X., 2021. Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo. Immunity 54, 2231-2244.e6.

  • Gao, Q., Yuan, S., Zhang, C., Wang, Ying, Wang, Yizhuo, He, G., Zhang, S., Altmeyer, R., Zou, G., 2015. Discovery of Itraconazole with Broad-Spectrum In Vitro Antienterovirus Activity That Targets Nonstructural Protein 3A. Antimicrob. Agents Chemother. 59, 2654–2665.

  • Guan, X., Che, Y., Wei, S., Li, S., Zhao, Z., Tong, Y., Wang, L., Gong, W., Zhang, Y., Zhao, Y., Wu, Y., Wang, S., Jiang, R., Huang, J., Liu, Y., Luo, W., Liao, Y., Hu, X., Zhang, W., Dai, Y., Jiang, G., Min, G., Liu, F., You, X., Xu, X., Li, J., Li, C., Fan, S., Hang, L., Huang, Q., Li, Q., 2020. Effectiveness and Safety of an Inactivated Enterovirus 71 Vaccine in Children Aged 6–71 Months in a Phase IV Study. Clin. Infect. Dis. 71, 2421–2427.

  • Horova, V., Lyoo, H., Różycki, B., Chalupska, D., Smola, M., Humpolickova, J., Strating, J.R.P.M., Kuppeveld, F.J.M. van, Boura, E., Klima, M., 2019. Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites. PLOS Pathog. 15, e1007962.

  • Jones, E., Pillay, T.D., Liu, F., Luo, L., Bazo-Alvarez, J.C., Yuan, C., Zhao, S., Chen, Q., Li, Y., Liao, Q., Yu, H., Rogier van Doorn, H., Sabanathan, S., 2018. Outcomes following severe hand foot and mouth disease: A systematic review and meta-analysis. Eur. J. Paediatr. Neurol. 22, 763–773.

  • Koh, W.M., Badaruddin, H., La, H., Chen, M.I.-C., Cook, A.R., 2018. Severity and burden of hand, foot and mouth disease in Asia: a modelling study. BMJ Glob. Health 3, e000442.

  • Lim, H.X., Poh, C.L., 2019. Insights into innate and adaptive immune responses in vaccine development against EV-A71. Ther. Adv. Vaccines Immunother. 7, 2515135519888998.

  • Lu, J.-Y., Brewer, G., Li, M.-L., Lin, K.-Z., Huang, C.-C., Yen, L.-C., Lin, J.-Y., 2021. Secretory Carrier Membrane Protein 3 Interacts with 3A Viral Protein of Enterovirus and Participates in Viral Replication. Microbiol. Spectr. 9, e00475-21.

  • Mandary, M.B., Poh, C.L., 2018. Changes in the EV-A71 Genome through Recombination and Spontaneous Mutations: Impact on Virulence. Viruses 10, 320.

  • Mao, Q., Wang, Y., Bian, L., Xu, M., Liang, Z., 2016. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev. Vaccines 15, 599–606.

  • McMinn, P.C., 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26, 91–107.

  • Nasri, D., Bouslama, L., Pillet, S., Bourlet, T., Aouni, M., Pozzetto, B., 2007. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev. Mol. Diagn. 7, 419–434.

  • Nguyen, T.T., Chiu, C.-H., Lin, C.-Y., Chiu, N.-C., Chen, P.-Y., Le, T.T.V., Le, D.N., Duong, A.H., Nguyen, V.L., Huynh, T.N., Truong, H.K., Phan, T.L., Nguyen, T.T.T., Shih, S.-R., Huang, C.-G., Weng, Y.-J., Hsieh, E.-F., Chang, S., Chen, C., Tai, I.-C., Huang, L.-M., 2022. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet 399, 1708–1717.

  • Norder, H., De Palma, A.M., Selisko, B., Costenaro, L., Papageorgiou, N., Arnan, C., Coutard, B., Lantez, V., De Lamballerie, X., Baronti, C., Solà, M., Tan, J., Neyts, J., Canard, B., Coll, M., Gorbalenya, A.E., Hilgenfeld, R., 2011. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antiviral Res. 89, 204–218.

  • Ooi, M.H., Wong, S.C., Lewthwaite, P., Cardosa, M.J., Solomon, T., 2010. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9, 1097–1105.

  • Qiu, Y., Xu, Y., Zhang, Y., Zhou, H., Deng, Y.-Q., Li, X.-F., Miao, M., Zhang, Q., Zhong, B., Hu, Y., Zhang, F.-C., Wu, L., Qin, C.-F., Zhou, X., 2017. Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals. Immunity 46, 992-1004.e5.

  • Rattanakomol, P., Srimanote, P., Tongtawe, P., Khantisitthiporn, O., Supasorn, O., Thanongsaksrikul, J., 2022. Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication. Sci. Rep. 12, 12846.

  • Rossi, P., Swapna, G.V.T., Huang, Y.J., Aramini, J.M., Anklin, C., Conover, K., Hamilton, K., Xiao, R., Acton, T.B., Ertekin, A., Everett, J.K., Montelione, G.T., 2010. A microscale protein NMR sample screening pipeline. J. Biomol. NMR 46, 11–22.

  • Ruan, Z., Liang, Y., Chen, Z., Yin, J., Li, C., Pan, P., Zhang, Q., Wu, J., Luo, Z., 2022. Enterovirus 71 non-structural protein 3A hijacks vacuolar protein sorting 25 to boost exosome biogenesis to facilitate viral replication. Front. Microbiol. 13, 1024899.

  • Salonen, A., Ahola, T., Kääriäinen, L., 2005. Viral RNA Replication in Association with Cellular Membranes, in: Marsh, M. (Ed.), Membrane Trafficking in Viral Replication. Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 139–173.

  • Schmidt, N.J., Lennette, E.H., Ho, H.H., 1974. An Apparently New Enterovirus Isolated from Patients with Disease of the Central Nervous System. J. Infect. Dis. 129, 304–309.

  • Shen, Y., Bax, A., 2013. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J. Biomol. NMR 56, 227–241.

  • Smola, M., Horova, V., Boura, E., Klima, M., 2020. Structural basis for hijacking of the host ACBD3 protein by bovine and porcine enteroviruses and kobuviruses. Arch. Virol. 165, 355–366.

  • Solomon, T., Lewthwaite, P., Perera, D., Cardosa, M.J., McMinn, P., Ooi, M.H., 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10, 778–790.

  • Teilum, K., Kunze, M.B.A., Erlendsson, S., Kragelund, B.B., 2017. (S)Pinning down protein interactions by NMR. Protein Sci. 26, 436–451.

  • Wang, S., Pang, Z., Fan, H., Tong, Y., 2023. Advances in anti-EV-A71 drug development research. J. Adv. Res., S2090-1232(23)00089-9

  • Xiao, X., Lei, X., Zhang, Z., Ma, Y., Qi, J., Wu, C., Xiao, Y., Li, L., He, B., Wang, J., 2017. Enterovirus 3A Facilitates Viral Replication by Promoting Phosphatidylinositol 4-Kinase IIIβ–ACBD3 Interaction. J. Virol. 91, e00791-17.

  • Yu, H., Cowling, B.J., 2019. Remaining challenges for prevention and control of hand, foot, and mouth disease. Lancet Child Adolesc. Health 3, 373–374.

  • Zhu, P., Ji, W., Li, D., Li, Z., Chen, Y., Dai, B., Han, S., Chen, S., Jin, Y., Duan, G., 2023. Current status of hand-foot-and-mouth disease. J. Biomed. Sci. 30, 15.